Edition:
United Kingdom

BioXcel Therapeutics Inc (BTAI.OQ)

BTAI.OQ on NASDAQ Stock Exchange Capital Market

6.25USD
12 Oct 2018
Change (% chg)

-- (--)
Prev Close
$6.25
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,299
52-wk High
$14.28
52-wk Low
$5.80

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.193
Mar '18 0.00 -0.374
FY 2017 Dec '17 0.00 -0.162
Sep '17 0.00 -0.059
Jun '17
Mar '17 0.00 -0.056
FY 2016 Dec '16 0.00 -0.036
Sep '16 0.00 -0.035
Jun '16
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 3 0.00 0.00 0.00 --
Quarter Ending Mar-19 1 0.00 0.00 0.00 --
Year Ending Dec-18 4 0.00 0.00 0.00 --
Year Ending Dec-19 4 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-18 5 -0.41 -0.32 -0.51 --
Quarter Ending Mar-19 1 -0.36 -0.36 -0.36 --
Year Ending Dec-18 5 -1.25 -1.12 -1.38 --
Year Ending Dec-19 5 -2.12 -1.90 -2.62 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.91 32.75
P/E High - Last 5 Yrs. -- 301.66 45.42
P/E Low - Last 5 Yrs. -- 92.42 24.25
Beta -- 0.93 0.89
Price to Sales (TTM) -- 115.65 5.74
Price to Book (MRQ) -- 15.58 5.00
Price to Tangible Book (MRQ) -- 14.67 6.57
Price to Cash Flow (TTM) -- 73.07 23.28
% Owned Institutions -- 14.71 2.26

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.51
Dividend Yield - 5 Year Avg -- 0.25 1.52
Dividend 5 Year Growth Rate -- 1.73 5.24
Payout Ratio(TTM) -- 16.54 43.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 413.24 8.00
Sales (TTM) vs TTM 1 Yr. Ago -- 79.21 5.62
Sales - 5 Yr. Growth Rate -- 32.28 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 27.96 20.60
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 40.04 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.58 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) -- 5.19 3.03
LT Debt to Equity (MRQ) -- 35.49 12.55
Total Debt to Equity (MRQ) -- 37.32 16.89
Interest Coverage (TTM) -- -102.94 32.71

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.99 54.34
Gross Margin - 5 Yr. Avg. -- 50.37 52.13
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -605.43 10.68
Operating Margin (TTM) -- -764.71 4.33
Operating Margin - 5 Yr. Avg. -- -626.59 6.11
Pre-Tax Margin (TTM) -- -738.48 5.20
Pre-Tax Margin - 5 Yr. Avg. -- -632.35 6.52
Net Profit Margin (TTM) -- -739.84 1.49
Net Profit Margin - 5 Yr. Avg. -- -635.37 2.79
Effective Tax Rate (TTM) -- 23.37 23.12
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,344,613 859,711,668
Net Income/Employee (TTM) -- 3,159,253 101,129,378
Receivable Turnover (TTM) -- 20.76 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) -- 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -0.24 11.13
Return on Assets - 5 Yr. Avg. -- 3.46 12.40
Return on Investment (TTM) -- 1.70 14.60
Return on Investment - 5 Yr. Avg. -- 2.51 16.13
Return on Equity (TTM) -- 3.17 16.33
Return on Equity - 5 Yr. Avg. -- 3.37 17.39

Performance for BioXcel Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 29.07%
# of Holders: 24
Total Shares Held: 4,548,441
3 Mo. Net Change: 172,515
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 1
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.